Search

Hydrogen sulfide (H2S), is a gasotransmitter with several key roles in metabolism and vascular function. The effects of H2S are dependent on concentration and target organ. For example, increased H2S concentrations impair liver metabolic function but protect against vascular dysfunction and atherosclerosis. Thiosulfate sulfurtransferase (TST), a nuclear encoded mitochondrial matrix enzyme, is proposed to be a component of the sulfide oxidising unit (SOU) which metabolises H2S. Preliminary data has shown that Tst deletion in mice (Tst-/-) increases circulating H2S levels measured in whole blood. Therefore, it was hypothesised that Tst-/- mice would exhibit worsened metabolic function in the liver but also protection of vascular function under conditions of vascular stress e.g. atherosclerosis. Liver metabolism was assessed by extensive metabolic phenotyping of Tst-/-mice fed control diet and in conditions of metabolic dysfunction induced by a high fat diet (HFD). Tst deletion altered glucose metabolism in mice; gluconeogenesis was increased in liver from Tst-/-mice fed control diet. Glucose intolerance in HFD-fed Tst-/-mice was also more severe than HFDfed C57BL/6 controls. In vitro metabolic investigations in primary hepatocytes isolated from Tst-/-mice demonstrated that mitochondrial ATP-linked and leak respiration were increased compared to controls. The effect of Tst deletion on vascular function was investigated in Tst- /-mice fed control or HFD using myography. Tst deletion did not alter vessel function when mice were maintained on a normal diet. HFD feeding (20 weeks) reduced maximal vessel constriction in the presence of endothelial nitric oxide synthase and cyclooxygenase inhibitors in C57BL/6 aorta. However, in Tst-/-mice fed HFD there was no reduction in maximal constriction suggesting a protective action of Tst deletion. The effects of Tst deletion on atherosclerotic lesions was investigated by generating double knock-out (DKO) mice by deletion of the Tst gene in ApoE-/- mice and (ApoE-/-Tst-/-). Atherosclerotic lesion formation was accelerated by feeding mice a western diet. Within the brachiocephalic branch lesion volume and total vessel volume were reduced in DKO mice fed western diet for 12 weeks, indicating that Tst deletion reduced lesion formation. Plasma cholesterol was reduced in DKO mice compared to ApoE-/- controls and a trend towards reduced systolic blood pressure was also noted. Overall this work supported the hypothesis that Tst deletion engenders metabolic dysfunction but vascular protection. The findings are consistent with the reported effects of increased H2S signalling. Overall inhibition of TST represents a novel target for treatment of atherosclerosis, with the caveat that glycaemia may be worsened due to hepatic metabolic dysfunction.

Obesity is associated with dysfunction of adipose tissue due to oxidative stress and inflammation, leading to insulin resistance. Thiosulfate sulfurtransferase (Tst) was previously identified as an adipose-expressed anti-diabetic gene that protects against diet-induced metabolic impairment when upregulated in adipose tissue of mice. TST is a mitochondrial enzyme involved in the metabolism of cyanide, reactive oxygen species (ROS) and endogenous hydrogen sulfide (H2S). This thesis tested the hypothesis that TST maintains metabolic health in the face of dietary obesity. To do this, I investigated the adipose-tissue phenotypes and metabolic consequences of Tst gene deletion (Tst–/– mice) and of adipose tissue-specific overexpression of human TST (Ad-hTST mice) after exposure to high fat diet (HFD). After 20 weeks of HFD, Tst–/– mice exhibited impaired glucose tolerance despite unchanged adipose tissue inflammatory cell infiltration, protein carbonylation and unfolded protein response activation. However, levels of mRNA encoding mitochondrial antioxidant enzymes including superoxide dismutase 2 and peroxiredoxin 3 were lower in Tst–/– mice on HFD. Unexpectedly, chow-fed Tst-/- mice had lower body weight and fat mass than wild-type controls highlighting a potential effect of Tst on fat accumulation with age. A new mouse model with high expression of human TST genetically targeted to adipose tissue (Ad-hTST) was developed using the LoxP / Cre recombinase expression system, with a parent line expressing Cre under the control of the adiponectin promoter to confer adipose specificity. The Ad-hTST mice were found to gain a similar amount of weight and fat mass to control mice when exposed to 6 weeks of HFD. However, Ad-hTST mice had impaired glucose tolerance with no change in inflammatory cell infiltration, mRNA levels of antioxidant enzymes or unfolded protein response genes. Thus, unexpectedly, overexpression of human TST in adipose tissue of mice results in a detrimental metabolic phenotype. In vivo and in vitro experiments were conducted to test the hypothesis that TST protects against ROS accumulation. Paraquat was tested as an inducer of oxidative stress in vivo in wild-type, Tst-/- and Tst+/- mice. At the doses used (25mg/kg and under), mice became unwell and lost weight, with no increase in markers of oxidative stress in adipose or lung. The production of mitochondrial ROS in response to exogenous hydrogen peroxide (H2O2) exposure was increased in primary adipocytes from Tst-/- mice in vitro. However, primary hepatocytes showed reduced mitochondrial ROS production in response to H2O2 exposure. ROS production in hepatocytes was unaffected by pre-incubation with a H2S donor, an inhibitor of H2S-producing enzyme CSE or N-acetyl-cysteine, an antioxidant. TST may therefore influence mitochondrial ROS production differently in cell types such as adipocytes and hepatocytes. Disposal of exogenous H2O2 was unchanged in primary adipocytes from Tst-/- and Ad-hTST mice, and this was not affected by pre-incubation with sodium thiosulfate, a TST substrate. Metabolic changes in response to HFD may be influenced by alteration in TST expression, however the current data suggest it is unlikely to occur through the prevention of excessive local ROS accumulation in adipose tissue. Mice lacking the Tst gene globally and mice with adipose-specific overexpression of the human TST gene have a similarly impaired metabolic response to HFD. The phenotype of adipose-specific human TST-overexpressing mice does not recapitulate the protective metabolic phenotype produced by overexpression of the endogenous mouse Tst gene. In conclusion, TST may influence adipose tissue due to its role in the oxidation of H2S, however, by the current means, it does not appear to substantially impact the response of this tissue to oxidative stress.

Salmonella enterica is an important cause of food poisoning and is responsible for approximately a billion human infections each year. Disease manifestation in humans varies from severe systemic enteric (typhoid) fever to self-limiting gastroenteritis depending upon the infecting S. enterica serovar. S. Typhimurium is responsible for acute gastroenteritis in humans but causes a typhoid-like disease in mice and thus serves as an important model for studying the pathogenesis of systemic salmonellosis. Following ingestion, S. Typhimurium employs a variety of virulence mechanisms to survive within its host and establishes infection in the intestinal tract by invading the epithelial cells. Recent studies have revealed the importance of sulfur compounds in the intestine, such as tetrathionate and thiosulfate for the disease progression. S. Typhimurium is capable of utilising these sulfur compounds as terminal electron acceptors for its anaerobic respiration and thus gains a growth advantage over host microbiota during infection. However, the regulation of sulfur availability within S. Typhimurium and the mechanisms involved in mitigating cellular sulfide toxicity are not well-defined. During this study, we have identified the sstRA operon in S. Typhimurium encoding a deduced SmtB/ArsR family of transcriptional regulatory protein (SstR) and a deduced rhodanese-family sulfurtransferase (SstA) and demonstrated a role in mitigating the effects of cellular sulfide toxicity. SstR has been confirmed to act as a transcriptional repressor from the sstRA operator-promoter and the SstR-dependent repression is alleviated by low pH and sulfide stress (sodium thiosulfate), consistent with a role for SstR in sensing sulfide stress to trigger gene expression. Electrophoretic mobility shift assays confirm binding of purified SstR to the sstRA operator-promoter region. Furthermore, a conserved pair of cysteine residues within SstR was identified to be crucial for alleviating SstR-mediated repression, with the substitution of either cysteine causing constitutive repression. This is consistent with SstR inducer-responsiveness involving a thiol-based redox switch. Importantly, S. Typhimurium mutants lacking the sstRA operon have reduced tolerance to sulfide stress, consistent with the sstRA operon having a role in cellular sulfide detoxification. Work is continuing to further characterise the roles of sstR and sstA in S. Typhimurium on their contributions to infections.

Hydrogen sulfide (H2S) is an endogenous gasotransmitter that regulates vascular function and blood pressure, and also protects the heart from injury associated with myocardial infarction (MI). The mitochondrial enzyme thiosulfate sulfurtransferase (TST) has a putative role in the breakdown of H2S but its role in the cardiovascular system is unknown. I hypothesised that TST reduces cardiovascular H2S availability and that inhibiting TST activity may therefore ameliorate cardiovascular pathology. In the heart, TST was expressed by cardiomyocytes and vascular smooth muscle cells. Tst-/- mice all survived to adulthood and had normal cardiac structure and function. Cardiac and hepatic H2S breakdown rates were reduced and H2S levels were higher in the blood of Tst-/- mice. However, in heart tissue, protein levels for the H2S-activated Nrf2 downstream targets, thioredoxin (Trx1) and heme oxygenase-1 (HO-1) were comparable. In contrast, protein levels for the cardiac specific H2S-synthetic enzyme, cystathionine gamma lyase (CSE) was reduced, suggesting a homeostatic negative feedback mechanism to maintain H2S at non-toxic levels. Respiration, measured using an oxygen-sensing electrode was normal in isolated mitochondria from whole Tst-/- compared to control C57BL6 hearts. Endothelial nitric oxide synthase (eNOS) protein expression was lower in Tst-/- hearts, highlighting potential cross talk between H2S and nitric oxide (NO) signalling. TST was expressed in whole aorta homogenates and in isolated endothelial cells from aorta and small intramuscular vessels of the hindlimb from C57BL/6N control mice. Myography and western blotting revealed a greater influence of NO in aorta from Tst-/- mice that was associated with increased phosphorylation of the activating serine1177 residue of eNOS (PeNOSSer1177). NO plays a lesser role in resistance arteries, but in comparison to control vessels, small mesenteric vessels from Tst-/- mice was more reliant on small and intermediate calcium activated potassium channels for relaxation. Tst-/- mice were normotensive, despite this alteration in the regulation of vascular tone. However, metabolic cage experiments identified that Tst-/- mice presented with diuresis, polydipsia, and increased urinary electrolyte excretion of sodium, potassium and chloride, possibly to compensate for increased vascular tone in order to maintain stable blood pressure. To investigate the role of TST in regulating the response to pathological challenge, MI was induced by coronary artery ligation (CAL). In control mice, gene expression of CSE was downregulated by 2 days after CAL, but TST expression was 12-fold increased, suggesting regulation of H2S bioavailability during the acute MI-healing phase. Tst-/- male mice had a 40% greater incidence of cardiac rupture during infarct healing and surviving Tst-/- mice had greater left ventricular dilatation and impaired function compared to controls. Ex vivo, isolated perfused hearts from Tst-/- mice were more susceptible to ischaemia/ reperfusion injury, suggesting an additional role of TST in determining cardiomyocyte susceptibility to injury. In conclusion, these data indicate that cardiovascular H2S bioavailability is regulated through degradation by TST. The data presented here provide evidence for significant tissue specific crosstalk between H2S synthetic and degradative mechanisms and between H2S and other local regulatory mechanisms, including ion channels and NOS. We infer TST has a physiological role in the kidney where its loss leads to changes in renal electrolyte and water handling, although other compensatory mechanisms prevent a change in blood pressure. Under conditions of pathological challenge following MI, loss of TST is detrimental, illustrating its key role in removal of H2S. The data refute the original hypothesis that TST inhibition would be protective against cardiovascular pathology. Further studies in mice with tissue specific deletion of TST are now required to more fully reveal the cardiovascular role of TST.